We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Operational Resiliency Protect HCA's Long-Term Profitability?
Read MoreHide Full Article
Key Takeaways
HCA's cost-control progress is helping offset inflation and protect profitability amid earnings headwinds.
HCA is using digital transformation and shared services to drive recurring productivity gains.
HCA targets 4-6% long-term adjusted EBITDA growth as unit-cost control supports volume growth.
HCA Healthcare, Inc. (HCA - Free Report) faces a significant earnings headwind from health insurance exchange disenrollment, with the company estimating a $1.0-$1.2 billion unfavorable impact in 2026. At the same time, professional fees and other operating costs remain elevated. Against this backdrop, its multi-year resiliency program is becoming an important tool for strengthening financial performance.
Same-facility cost per equivalent admission was essentially flat year over year in the second quarter and improved 1.4% sequentially. The combined cost of salaries and benefits, supplies, and other operating expenses per adjusted admission was only flat to slightly higher than a year earlier. This suggests that HCA is gaining greater control over its underlying cost base, even as the operating environment remains challenging. The progress is important because better cost control can help HCA offset inflation and protect profitability.
HCA’s investments in digital transformation, global capabilities and expanded shared services could support recurring productivity gains and reduce reliance on temporary cost-cutting measures. That matters as elective surgery remains pressured by affordability concerns, while changes in payer mix weigh on earnings.
If these initiatives consistently deliver productivity improvements, the resiliency program transitions from an emergency buffer into a durable margin driver. The ability to keep unit costs in check while maintaining volume growth could become an increasingly important contributor to HCA’s targeted 4-6% long-term adjusted EBITDA growth.
How Do Peers Compare?
HCA is not alone in prioritizing operational efficiency. Medical peers such as Tenet Healthcare Corporation (THC - Free Report) and Universal Health Services, Inc. (UHS - Free Report) are also pursuing efficiency initiatives and expanding outpatient capabilities to drive growth and profitability.
Tenet Healthcare has strengthened profitability through operational discipline and a growing ambulatory-care platform. THC’s focus on efficiency, higher-acuity care and portfolio optimization strengthens earnings resilience and supports healthier margins.
Universal Health continues to emphasize disciplined cost management and operational efficiency across its hospital and behavioral-health businesses. UHS’ ability to control expenses while sustaining earnings growth makes its margin resilience an important factor for investors tracking healthcare operators.
HCA’s Price Performance, Valuation & Estimates
Shares of HCA Healthcare have gained 3.8% over the past year compared with the industry's 12.8% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, HCA trades at a forward price-to-earnings ratio of 13.44X, down from the industry average of 16.69X. HCA carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HCA’s 2026 earnings is pegged at $29.42 per share, implying a 4.3% jump from the year-ago period’s level.
View the Zacks #1 Rank List
Image: Bigstock
Can Operational Resiliency Protect HCA's Long-Term Profitability?
Key Takeaways
HCA Healthcare, Inc. (HCA - Free Report) faces a significant earnings headwind from health insurance exchange disenrollment, with the company estimating a $1.0-$1.2 billion unfavorable impact in 2026. At the same time, professional fees and other operating costs remain elevated. Against this backdrop, its multi-year resiliency program is becoming an important tool for strengthening financial performance.
Same-facility cost per equivalent admission was essentially flat year over year in the second quarter and improved 1.4% sequentially. The combined cost of salaries and benefits, supplies, and other operating expenses per adjusted admission was only flat to slightly higher than a year earlier. This suggests that HCA is gaining greater control over its underlying cost base, even as the operating environment remains challenging. The progress is important because better cost control can help HCA offset inflation and protect profitability.
HCA’s investments in digital transformation, global capabilities and expanded shared services could support recurring productivity gains and reduce reliance on temporary cost-cutting measures. That matters as elective surgery remains pressured by affordability concerns, while changes in payer mix weigh on earnings.
If these initiatives consistently deliver productivity improvements, the resiliency program transitions from an emergency buffer into a durable margin driver. The ability to keep unit costs in check while maintaining volume growth could become an increasingly important contributor to HCA’s targeted 4-6% long-term adjusted EBITDA growth.
How Do Peers Compare?
HCA is not alone in prioritizing operational efficiency. Medical peers such as Tenet Healthcare Corporation (THC - Free Report) and Universal Health Services, Inc. (UHS - Free Report) are also pursuing efficiency initiatives and expanding outpatient capabilities to drive growth and profitability.
Tenet Healthcare has strengthened profitability through operational discipline and a growing ambulatory-care platform. THC’s focus on efficiency, higher-acuity care and portfolio optimization strengthens earnings resilience and supports healthier margins.
Universal Health continues to emphasize disciplined cost management and operational efficiency across its hospital and behavioral-health businesses. UHS’ ability to control expenses while sustaining earnings growth makes its margin resilience an important factor for investors tracking healthcare operators.
HCA’s Price Performance, Valuation & Estimates
Shares of HCA Healthcare have gained 3.8% over the past year compared with the industry's 12.8% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, HCA trades at a forward price-to-earnings ratio of 13.44X, down from the industry average of 16.69X. HCA carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HCA’s 2026 earnings is pegged at $29.42 per share, implying a 4.3% jump from the year-ago period’s level.
Image Source: Zacks Investment Research
HCA currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.